Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups
- PMID: 22982095
- DOI: 10.1016/j.cgh.2012.09.007
Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups
Abstract
Background & aims: The incidence of hepatocellular carcinoma (HCC) and associated risk factors in patients with alcoholic cirrhosis are not well defined. Surveillance for HCC among patients with cirrhosis who do not have hepatitis B is cost effective only if the expected risk of HCC exceeds 1.5% per year. We performed a prospective study to determine the incidence of HCC among patients with alcoholic cirrhosis and to identify risk factors.
Methods: We analyzed data from a surveillance program of 450 patients, aged 40 to 75 years, with alcoholic cirrhosis of Child-Pugh class A or B; patients were enrolled at the liver unit of a tertiary center from September 1992 through March 2010. Data were collected on 20 demographic, clinical, and laboratory variables at the start of the study. Patients were examined every 3 to 6 months for 5 years to identify risk factors for HCC; incidence was determined from a median follow-up time of 42 months.
Results: Over the follow-up period, 62 patients developed HCC (43 in the first 5 y of follow-up evaluation), with an annual incidence of 2.6%. By using multivariate analysis, age 55 years and older (hazard ratio, 2.39; 95% confidence interval, 1.27-4.51) and platelet counts less than 125 × 10(3)/mm(3) (hazard ratio, 3.29; 95% confidence interval, 1.39-7.85) were associated independently with the development of HCC. These variables were used to define 3 risk groups. The annual incidence of HCC in the group without either of these factors was 0.3% (n = 93), the annual incidence with 1 factor was 2.6% (n = 228), and the annual incidence with both factors was 4.8% (n = 129) (P < .0001).
Conclusions: The annual incidence of HCC among patients with alcoholic cirrhosis of Child-Pugh class A or B is around 2.5%. Age and platelet count can be used to classify the patients in 3 different risk groups for HCC development within the next 5 years.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.Clin Gastroenterol Hepatol. 2006 Aug;4(8):1062-8. doi: 10.1016/j.cgh.2006.05.013. Epub 2006 Jul 14. Clin Gastroenterol Hepatol. 2006. PMID: 16844421
-
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690
-
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.Hepatology. 2003 Mar;37(3):520-7. doi: 10.1053/jhep.2003.50093. Hepatology. 2003. PMID: 12601348
-
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2023 May;21(5):1169-1177. doi: 10.1016/j.cgh.2022.06.032. Epub 2022 Aug 5. Clin Gastroenterol Hepatol. 2023. PMID: 35940513 Free PMC article. Review.
-
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2017 Aug;15(8):1207-1217.e4. doi: 10.1016/j.cgh.2017.02.006. Epub 2017 Feb 12. Clin Gastroenterol Hepatol. 2017. PMID: 28215616 Free PMC article. Review.
Cited by
-
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.Gut. 2023 Feb;72(2):381-391. doi: 10.1136/gutjnl-2022-327196. Epub 2022 Jul 4. Gut. 2023. PMID: 35788059 Free PMC article.
-
Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.Clin Liver Dis. 2020 Nov;24(4):549-576. doi: 10.1016/j.cld.2020.06.002. Epub 2020 Aug 25. Clin Liver Dis. 2020. PMID: 33012445 Free PMC article. Review.
-
ACG Clinical Guideline: Alcohol-Associated Liver Disease.Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1. Am J Gastroenterol. 2024. PMID: 38174913 Free PMC article.
-
Risk Factors for Hepatocellular Carcinoma: A Historical Perspective.Clin Liver Dis (Hoboken). 2021 Oct 29;18(Suppl 1):1-13. doi: 10.1002/cld.1042. eCollection 2021 Oct. Clin Liver Dis (Hoboken). 2021. PMID: 34745580 Free PMC article. Review.
-
Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis.Gastroenterol Res Pract. 2020 Apr 9;2020:1892584. doi: 10.1155/2020/1892584. eCollection 2020. Gastroenterol Res Pract. 2020. PMID: 32454812 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical